Group B Streptococcus transcriptome when interacting with brain endothelial cells
Journal of Bacteriology · 2024
DOI: 10.1128/jb.00087-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Bacteriology, 2024. Verfasst von Nadine Vollmuth und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, University of Alabama, Tuscaloosa, Alabama, USA. Hauptthemen laut MEDLINE: Streptococcus agalactiae, Endothelial Cells, Transcriptome, Brain. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Alexander von Humboldt-Stiftung (AvH), HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS), NINDS NIH HHS.
Abstract (Originalsprache)
Bacterial meningitis is a life-threatening infection of the central nervous system (CNS) that occurs when bacteria are able to cross the blood–brain barrier (BBB) or the meningeal–cerebrospinal fluid barrier (mBCSFB). The BBB and mBCSFB comprise highly specialized brain endothelial cells (BECs) that typically restrict pathogen entry. Group B Streptococcus (GBS or Streptococcus agalactiae ) is the leading cause of neonatal meningitis. Until recently, identification of GBS virulence factors has relied on genetic screening approaches. Instead, we here conducted RNA-seq analysis on GBS when interacting with induced pluripotent stem cell-derived BECs (iBECs) to pinpoint virulence-associated genes. Of the 2,068 annotated protein-coding genes of GBS, 430 transcripts displayed significant changes in expression after interacting with BECs. Notably, we found that the majority of differentially expressed GBS transcripts were downregulated (360 genes) during infection of iBECs. Interestingly, codY , encoding a pleiotropic transcriptional repressor in low-G + C Gram-positive bacteria, was identified as being highly downregulated. We conducted qPCR to confirm the codY downregulation observed via RNA-seq during the GBS–iBEC interaction and obtained codY mutants in three different GBS background parental strains. As anticipated from the RNA-seq results, the ∆ codY strains were more adherent and invasive in two in vitro BEC models. Together, this demonstrates the utility of RNA-seq during the BEC interaction to identify GBS virulence modulators. IMPORTANCE Group B Streptococcus (GBS) meningitis remains the leading cause of neonatal meningitis. Research work has identified surface factors and two-component systems that contribute to GBS disruption of the blood–brain barrier (BBB). These discoveries often relied on genetic screening approaches. Here, we provide transcriptomic data describing how GBS changes its transcriptome when interacting with brain endothelial cells. Additionally, we have phenotypically validated these data by obtaining mutants of a select regulator that is highly down-regulated during infection and testing on our BBB model. This work provides the research field with a validated data set that can provide an insight into potential pathways that GBS requires to interact with the BBB and open the door to new discoveries.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Sciences, University of Alabama, Tuscaloosa, Alabama, USA.
- Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
- Richard King Mellon Institute for Pediatric Research, UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.
- Department of Biology and Biotechnology, University of Pavia, Pavia, Italy.
- Institute of Molecular Infection Biology (IMIB), University of Wuerzburg, Wuerzburg, Germany.
- Helmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz Centre for Infection Research (HZI), Wuerzburg, Germany.
ORCID-Profile: Nadine Vollmuth, Thomas A Hooven, Giulia Barbieri, Alexandra Schubert-Unkmeir, Brandon J Kim
Förderung
- Alexander von Humboldt-Stiftung (AvH)
- HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS)
- NINDS NIH HHS
- NIAID NIH HHS
Zitieren
APA
Vollmuth, N., Bridgers, B. E., Armstrong, M. L., Wood, J. F., Gildea, A. R., Espinal, E. R., Hooven, T. A., Barbieri, G., Westermann, A. J., Sauerwein, T., Foerstner, K. U., Schubert-Unkmeir, A., & Kim, B. J. (2024). Group B Streptococcus transcriptome when interacting with brain endothelial cells. Journal of Bacteriology. https://doi.org/10.1128/jb.00087-24
Vancouver
Vollmuth N, Bridgers BE, Armstrong ML, Wood JF, Gildea AR, Espinal ER, et al. Group B Streptococcus transcriptome when interacting with brain endothelial cells. Journal of Bacteriology. 2024. doi:10.1128/jb.00087-24
BibTeX
@article{Vollmuth2024,
author = {Vollmuth, Nadine and Bridgers, Bailey E and Armstrong, Madelyn L and Wood, Jacob F and Gildea, Abigail R and Espinal, Eric R and Hooven, Thomas A and Barbieri, Giulia and Westermann, Alexander J and Sauerwein, Till and Foerstner, Konrad U and Schubert-Unkmeir, Alexandra and Kim, Brandon J},
title = {Group B Streptococcus transcriptome when interacting with brain endothelial cells},
journal = {Journal of Bacteriology},
year = {2024},
doi = {10.1128/jb.00087-24}
}
EUVIMED